Feb 12 2010
IntegraMed America, Inc. (NASDAQ: INMD) today announced that it has
priced a public offering of 2,500,000 shares of its common stock at a
price to the public of $7.50 per share, of which 2,000,000 shares are
being offered through the underwriters named below and 500,000 shares
are being offered directly by IntegraMed to IAT Reinsurance Company
Ltd., IntegraMed’s largest stockholder.
The approximately $17 million of net proceeds, after deducting
underwriting discounts, commissions and expected offering expenses
payable by IntegraMed, are intended to be used to accelerate the
addition of new partner fertility centers, to accelerate the pace of new
vein clinic openings in 2010, or for general working capital and other
corporate purposes. The offering is expected to close on or about
February 18, 2010, subject to the satisfaction of customary closing
conditions.
The underwriters have been granted a 30-day option to purchase up to an
additional 300,000 shares to cover over-allotments, if any.